Clinical Trial Update: Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial of alemtuzumab combined with chemotherapy for peripheral T-cell lymphoma (stages I–IV); current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma
• Small Intestine Cancer

Drugs mentioned

• Alemtuzumab (Alemtuzumab)

Snippet

Sponsor: Cancer Research UK | Conditions: Lymphoma, Small Intestine Cancer | Phase 1 | Status: UNKNOWN